University of Vermont

College of Medicine Faculty Receive Recognition at April 4 VT Invention2Venture Conference

Jason Bates
Jason Bates, Ph.D., professor of medicine, will, along with Peter Spector, M.D., professor of medicine, receive an award for their newly-licensed company, Visible Electrophysiology, LLC, at the Invention to Venture (I2V) Conference.

The annual Invention to Venture (I2V) Conference brings together academic researchers, students, entrepreneurs and business leaders from across the state to collaboratively focus on entrepreneurship, job creation, and economic growth. The 2013 event attracted a record 140 attendees and offered a new, highly interactive, roundtable discussion format offering discussion on a wide variety of topics, and an awards session at which several University of Vermont College of Medicine faculty were recognized.

Presented by the University of Vermont’s Office of Technology Commercialization, the Vermont Technology Council and the Vermont Center for Emerging Technologies, the conference is in its eighth year. The 2013 keynote presentation was delivered by Rich Tarrant, Jr., founder and CEO of MyWebGrocer.

Among the faculty members who received awards were: Peter Spector, M.D., professor of medicine, and Jason Bates, Ph.D., professor of medicine, for their newly-licensed company Visible Electrophysiology, LLC; Haematologic Technologies collaborators, including Kathleen Brummel-Zeidins, Ph.D., associate professor of biochemistry, Kenneth Mann, Ph.D., professor emeritus of biochemistry, Stephen Everse, Ph.D., associate professor of biochemistry, and Thomas Orfeo, Ph.D., research associate of biochemistry. Merecedes Rincon, Ph.D., professor of medicine, and Wendy Neveu, Ph.D., M.D.-Ph.D. student, who were inducted into the Hall of Fame for their work with BioMosaics/Anti-MCJ antibodies. In addition, a number of patent recipients were honored, including Rincon, Neveu, Mann, Cory Teuscher, Ph.D., professor of medicine, and George Wellman, Ph.D., associate professor of pharmacology.

Roundtable Discussion topics and leaders included:

I.P. Protection with Kathryn Doyle, Ph.D., J.D., Riverside Law

FDA Regulated: Process to Market with Bethany Hills, M.P.H., J.D., Partner, Hodgson Russ Attorneys

Unregulated Technologies: Proof to Concept with Tanya Kanigan, Ph.D., Chief Operating Office of Genomic Expression, Inc., and Principal and Founder, Proof of Market

Finding the Money: Vermont Financial Resources with Janice St. Onge, Deputy Director, Vermont Sustainable Jobs Fund, and President, VSJF Flexible Capital Fund, L3C; Jo Bradley, M.B.A., Chief Executive Officer, VT Economic Development Authority (VEDA); and Andrew Stickney, M.B.A., Vice President, Vermont Center for Emerging Technologies (VCET) 

Lessons Learned from a CEO with Jack Glaser, President, MBF Bioscience

SBIR/STTR/EPSCoR Phase 0 with Robert Davis, CEO and Co-Founder, Stromatec, and Patrick Clemins, Ph.D., Cyber Education Specialist, VT EPSCoR

Industry Collaboration with Lennart Lundblad, Ph.D., UVM Assistant Professor of Medicine, Division of Pulmonary and Critical Care Medicine

How to Build a Business Team
with Steve Arms, Principle, Swarms Ventures, LLC, and Founder and President, MicroStrain, Inc.

The Pitch: Getting to Yes with Lars Hasselblad Torres, Director, Office of the Creative Economy, Vermont Agency of Commerce and Community Development

Corporate Structure
with Rocki Lee DeWitt, M.P.H.I., Ph.D., UVM Professor of Management, School of Business Administration, and Jeff McMahan, J.D., Partner, Dinse Knapp McAndrew Attorneys

Learn more about the I2V event and presenters.